About PetMedix
PetMedix is a company based in Babraham (United Kingdom) founded in 2017 by Thomas Weaver was acquired by Zoetis in September 2023.. PetMedix has raised $47.46 million across 3 funding rounds from investors including Tencent, Zoetis and Parkwalk. The company has 44 employees as of January 31, 2022. PetMedix operates in a competitive market with competitors including Zoetis, Ceva, QBiotics, Bio-Sourcing and Hester Biosciences, among others.
- Headquarter Babraham, United Kingdom
- Employees 44 as on 31 Jan, 2022
- Founders Thomas Weaver
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Petmedix Ltd
- Date of Incorporation 05 Dec, 2017
- Jurisdiction CAMBRIDGE, CAMBRIDGESHIRE, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PetMedix
PetMedix has successfully raised a total of $47.46M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $37 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $37.0M
-
First Round
First Round
(26 Feb 2019)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Series B - PetMedix | Valuation | Parkwalk | |
| May, 2020 | Amount | Series A - PetMedix | Valuation | Cambridge Innovation Capital |
|
| Feb, 2019 | Amount | Series A - PetMedix | Valuation | Digitalis Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PetMedix
PetMedix has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Zoetis and Parkwalk. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech companies are invested in by Parkwalk venture capital firm.
|
Founded Year | Domain | Location | |
|
Digitalis Ventures is engaged in health-focused investments.
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in life sciences and deep tech.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PetMedix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PetMedix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Petmedix Comparisons
Competitors of PetMedix
PetMedix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, QBiotics, Bio-Sourcing and Hester Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
|
| domain | founded_year | HQ Location |
Manufacturer of animal vaccines and healthcare products
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Petmedix
Frequently Asked Questions about PetMedix
When was PetMedix founded?
PetMedix was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is PetMedix located?
PetMedix is headquartered in Babraham, United Kingdom. It is registered at Babraham, Cambridgeshire, United Kingdom.
Who is the current CEO of PetMedix?
Thomas Weaver is the current CEO of PetMedix. They have also founded this company.
Is PetMedix a funded company?
PetMedix is a funded company, having raised a total of $47.46M across 3 funding rounds to date. The company's 1st funding round was a Series A of $10.46M, raised on Feb 26, 2019.
How many employees does PetMedix have?
As of Jan 31, 2022, the latest employee count at PetMedix is 44.
What does PetMedix do?
PetMedix was founded in 2017 in Babraham, United Kingdom, within the biotechnology sector focused on veterinary medicine. Monoclonal antibody therapeutics for pets are developed to address cancer, inflammation, and other conditions. The Ky9 and Felyne platforms are utilized to generate these antibodies, supporting operations in therapeutic innovation for animal health. Leadership includes co-founder Thomas Weaver as CEO.
Who are the top competitors of PetMedix?
Who are PetMedix's investors?
PetMedix has 6 investors. Key investors include Tencent, Zoetis, Parkwalk, Digitalis Ventures, and Cambridge Innovation Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.